MTHFR rs1801159: What Your Genotype Means
The rs1801159 variant is a polymorphism located within the MTHFR gene. It is currently being evaluated for its potential clinical relevance in predicting responses to certain anticancer drug therapies.
What each genotype means
Typical enzyme activity
This genotype is the common form of the MTHFR gene and is associated with standard enzyme function. While this gene is involved in folate metabolism and is often studied in the context of drug response, this specific genotype is generally considered to have a standard profile. Please discuss any concerns regarding medication response with your healthcare provider.
This is a very common genotype found in the majority of the global population.
Potential metabolic variation
This genotype indicates you carry one copy of the variant, which is being evaluated for its potential role in how the body processes certain anticancer drugs. Current clinical evidence regarding the impact of this variant on drug response is limited and sometimes inconsistent. Please consult your pharmacist or physician to determine if this information is relevant to your specific treatment.
This genotype is common and found at varying frequencies across most ancestral groups.
Potential metabolic variation
This genotype represents the variant form of the MTHFR gene, which is being studied for its potential influence on the efficacy and safety of certain medications. The clinical utility of this genotype for guiding treatment decisions remains unclear, as research findings have been mixed. You should discuss your treatment options and any potential side effects with your clinical team.
This genotype is relatively common in many populations worldwide.
Understanding the rs1801159 Variant
The rs1801159 variant is a single nucleotide polymorphism (SNP) found within the MTHFR gene, which encodes the methylenetetrahydrofolate reductase enzyme. This enzyme plays a critical role in the folate metabolism pathway, which is essential for DNA synthesis, repair, and methylation. In the context of pharmacogenomics, researchers investigate how specific genetic variations like rs1801159 influence the way an individual's body processes medications. By studying this variant, scientists aim to understand if it contributes to the interindividual variability observed in drug efficacy and toxicity. While the variant is well-documented in genetic databases, its functional impact on enzyme activity remains a subject of ongoing scientific inquiry. It is important to note that genetic variants do not act in isolation; they often interact with other genes, environmental factors, and lifestyle choices to influence health outcomes.
Research and Clinical Associations
Current research into rs1801159 is largely focused on its potential role in pharmacogenomics, particularly regarding anticancer drug response profiles. Some studies have examined this variant in diverse populations, including Nigerian cohorts, to determine if it serves as a biomarker for treatment outcomes. The evidence strength for this association is currently considered moderate, meaning that while there are observed statistical correlations, more robust clinical validation is required before it can be widely used in routine medical practice. In the field of pharmacogenetics, the goal is to move toward personalized medicine, where treatment plans are tailored to an individual's genetic makeup. However, the clinical utility of rs1801159 for predictive dosing strategies is not yet established. Researchers continue to conduct studies to clarify whether this variant significantly alters drug metabolism or toxicity risks in patients undergoing chemotherapy.
Interpreting Your Genetic Information
If you have received information about your rs1801159 genotype, it is essential to understand that this data is for educational purposes and should not be used to make medical decisions. Genetic associations are statistical in nature and do not guarantee a specific health outcome or drug response. Many factors, including age, diet, overall health, and other medications, play a significant role in how your body reacts to treatment. You cannot and should not use this information to adjust your medication dosage or stop a prescribed therapy. If you are concerned about how a specific drug might affect you, or if you are interested in how your genetics may influence your treatment plan, please discuss this with your clinician or pharmacist. They are the best resources to help you interpret your results in the context of your complete medical history and current clinical needs.
How common is this variant?
The rs1801159 variant is considered a common polymorphism, with its frequency varying across different ancestral populations.
Frequently asked questions
What is the MTHFR gene?
The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase. This enzyme is vital for the chemical processing of folate, a B vitamin, which is necessary for DNA production and repair.
Can I use this information to change my medication?
No. You should never change your medication dosage or stop taking a prescribed drug based on genetic test results. Always consult your doctor or pharmacist before making any changes to your treatment plan.
Is rs1801159 a diagnostic test?
No, rs1801159 is a genetic variant, not a diagnostic test. While it is studied for its potential role in drug response, it is not used to diagnose any specific disease or condition.
Where can I find more information about pharmacogenomics?
You can find reliable information on pharmacogenomics through resources like the Clinical Pharmacogenetics Implementation Consortium (CPIC) or MedlinePlus Genetics, which provide evidence-based summaries on how genes affect drug response.
Sources & further reading
Educational information only, last refreshed 11/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801159?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Functional polymorphism influencing homocysteine dynamics and vascular endothelial recovery during high-intensity training.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The C677T variant in the MTHFR gene is associated with reduced enzyme activity and mild hyperhomocysteinemia, particularly in individuals with low folate intake.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.